Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darrell R Galloway

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|October 6, 2004
DNA vaccines against anthraxDarrell R Galloway, Les Baillie
Molecular Biotechnology|November 16, 2004
Synthesis and assembly of anthrax lethal factor-cholera toxin B-subunit fusion protein in transgenic potatoTae-Geum Kim, Darrell R Galloway, William H R Langridge
Vaccine|October 16, 2007
Analysis of peptide mimotopes of Burkholderia pseudomallei exopolysaccharideJoseph B Legutki, Michelle Nelson, Richard Titball, et al.
Genome Biology|January 12, 2005
Microarray-based resequencing of multiple Bacillus anthracis isolatesMichael E Zwick, Farrell Mcafee, David J Cutler, et al.
FEMS Immunology and Medical Microbiology|March 16, 2011
The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthraxKaren E Brenneman, Mehmet Doganay, Arya Akmal, et al.
FEMS Immunology and Medical Microbiology|June 8, 2002
Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosaBrian M Price, J Barten Legutki, Darrell R Galloway, et al.
BMC Microbiology|April 8, 2006
The Bacillus anthracis chromosome contains four conserved, excision-proficient, putative prophagesShanmuga Sozhamannan, Michael D Chute, Farrell D McAfee, et al.
Frontiers in Immunology|November 17, 2022
The magnitude of the germinal center B cell and T follicular helper cell response predicts long-lasting antibody titers to plague vaccinationDarrell R Galloway, Nguyen X Nguyen, Jiahui Li, et al.
Frontiers in Immunology|April 12, 2024
Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in miceDarrell R Galloway, Jiahui Li, Nguyen X Nguyen, et al.
Vaccines|February 26, 2022
Predictors of Survival after Vaccination in a Pneumonic Plague ModelBarry D Moore, Clair Macleod, Lisa Henning, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|October 6, 2004
DNA vaccines against anthraxDarrell R Galloway, Les Baillie
Molecular Biotechnology|November 16, 2004
Synthesis and assembly of anthrax lethal factor-cholera toxin B-subunit fusion protein in transgenic potatoTae-Geum Kim, Darrell R Galloway, William H R Langridge
Vaccine|October 16, 2007
Analysis of peptide mimotopes of Burkholderia pseudomallei exopolysaccharideJoseph B Legutki, Michelle Nelson, Richard Titball, et al.
Genome Biology|January 12, 2005
Microarray-based resequencing of multiple Bacillus anthracis isolatesMichael E Zwick, Farrell Mcafee, David J Cutler, et al.
FEMS Immunology and Medical Microbiology|March 16, 2011
The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthraxKaren E Brenneman, Mehmet Doganay, Arya Akmal, et al.
FEMS Immunology and Medical Microbiology|June 8, 2002
Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosaBrian M Price, J Barten Legutki, Darrell R Galloway, et al.
BMC Microbiology|April 8, 2006
The Bacillus anthracis chromosome contains four conserved, excision-proficient, putative prophagesShanmuga Sozhamannan, Michael D Chute, Farrell D McAfee, et al.
Frontiers in Immunology|November 17, 2022
The magnitude of the germinal center B cell and T follicular helper cell response predicts long-lasting antibody titers to plague vaccinationDarrell R Galloway, Nguyen X Nguyen, Jiahui Li, et al.
Frontiers in Immunology|April 12, 2024
Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in miceDarrell R Galloway, Jiahui Li, Nguyen X Nguyen, et al.
Vaccines|February 26, 2022
Predictors of Survival after Vaccination in a Pneumonic Plague ModelBarry D Moore, Clair Macleod, Lisa Henning, et al.
Pageof 2